VistaGen Therapeutics, Inc. Common Stock (VTGN)
VistaGen Therapeutics, Inc. Common Stock (VTGN) has a 21-report earnings history dating back to Jun 29, 2021. Its average absolute post-earnings move is ±9.02%, and 47.6% of those reactions were positive. Its largest post-earnings gain was +23.04% (Nov 10, 2022) and its largest decline was -26.85% (Feb 07, 2023). The next earnings report is predicted for 2026-11-10 (estimated).
Earnings reactions
How VTGN moved on each past earnings report.
Earnings Impact
Total Earnings
21
Avg Abs. Movement
±9.02%
Positive %
47.6%
Negative %
52.4%
Historical Earnings Statistics
| Date | Timing | Earnings move | SEC Filing |
|---|---|---|---|
| Jun 15, 2026 | ☽ POST | +19.91% | open_in_new |
| Feb 12, 2026 | ☽ POST | -6.79% | open_in_new |
| Nov 13, 2025 | ☽ POST | -1.18% | open_in_new |
| Aug 07, 2025 | ☽ POST | +8.09% | open_in_new |
Earnings Count
21
Total earnings in dataset
Avg Abs. Movement
±9.02%
Avg % price change on earnings
Institutional ownership
Holdings as of Mar 31, 2026 · SEC 13-F
SEC Filing Types
Recent SEC Filings
10 most recent| Form | Date Filed | View on EDGAR |
|---|---|---|
| 4 | 20260702 | open_in_new SEC.gov |
| 4 | 20260702 | open_in_new SEC.gov |
| 4 | 20260702 | open_in_new SEC.gov |
| 8-K | 20260630 | open_in_new SEC.gov |
| 8-K | 20260617 | open_in_new SEC.gov |
| 10-K | 20260615 | open_in_new SEC.gov |
| 8-K | 20260615 | open_in_new SEC.gov |
| 8-K | 20260609 | open_in_new SEC.gov |
| 3 | 20260519 | open_in_new SEC.gov |
| 4 | 20260519 | open_in_new SEC.gov |
Frequently asked about VTGN earnings
When does VistaGen Therapeutics, Inc. Common Stock report earnings next? expand_more
VistaGen Therapeutics, Inc. Common Stock (VTGN)'s next earnings date is estimated for 2026-11-10. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.
How much does VTGN stock move after earnings? expand_more
Over 21 reports, VTGN has moved an average of ±9.02% the session after earnings, closing higher 47.6% of the time.
What was VTGN's biggest post-earnings move? expand_more
VTGN's largest post-earnings gain on record was +23.04% on Nov 10, 2022, and its largest decline was -26.85% on Feb 07, 2023.
Where can I find VistaGen Therapeutics, Inc. Common Stock's SEC filings? expand_more
All of VistaGen Therapeutics, Inc. Common Stock's SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.
Sector peers
- Aardvark Therapeutics, Inc. (AARD) earnings history chevron_right
- AbCellera Biologics Inc. Common Shares (ABCL) earnings history chevron_right
- ABEONA THERAPEUTICS INC. (ABEO) earnings history chevron_right
- Acumen Pharmaceuticals, Inc. Common Stock (ABOS) earnings history chevron_right
- Arbutus Biopharma Corp (ABUS) earnings history chevron_right
- ABVC BioPharma, Inc. Common Stock (ABVC) earnings history chevron_right
- ACADIA PHARMACEUTICALS INC (ACAD) earnings history chevron_right
- Adicet Bio, Inc. Common Stock (ACET) earnings history chevron_right
- Acadia Healthcare Company, Inc. Common Stock (ACHC) earnings history chevron_right
- Achieve Life Sciences, Inc. Common Shares (ACHV) earnings history chevron_right